Clinical Trial Update: A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH [Phase 4]

View source ↗

Summary

Phase 4 trial investigating PADN for improving functional capacity and hemodynamics in pulmonary arterial hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• PADN

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED